Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting

被引：1
|
作者：
Muscente, Francesca [1 ,2 ]
Tautermann, Gerda [3 ,4 ]
De Caterina, Raffaele [1 ,2 ]
机构：
[1] DAnnunzio Univ, Inst Cardiol, Chieti, Italy
[2] DAnnunzio Univ, Dept Cardiol, Chieti, Italy
[3] Acad Teaching Hosp, Dept Med & Cardiol, Feldkirch, Austria
[4] VIVIT Inst, Feldkirch, Austria
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2018年 / 19卷
关键词：
acute coronary syndrome; anticoagulation; antiplatelet drugs; atrial fibrillation; bleeding; net clinical benefit; stent thrombosis; DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY; ANTITHROMBOTIC THERAPY; TRIPLE THERAPY; MYOCARDIAL-INFARCTION; CARDIAC EVENTS; WORKING GROUP; WARFARIN; INTERVENTION; ASPIRIN;
D O I：
10.2459/JCM.0000000000000597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E40 / E45
页数：6
相关论文
共 50 条
  • [31] Novel Oral Anticoagulation in Management of Venous Thromboembolism, Atrial Fibrillation, and Acute Coronary Syndrome
    Khemasuwan, Danai
    Suramaethakul, Nuttanun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (05) : 476 - 486
  • [32] Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants
    Bocchino, Pier Paolo
    Angelini, Filippo
    Toso, Elisabetta
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 635 - 648
  • [33] Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study
    De Luca, Leonardo
    Rubboli, Andrea
    Bolognese, Leonardo
    Gonzini, Lucio
    Urbinati, Stefano
    Murrone, Adriano
    Scotto di Uccio, Fortunato
    Ferrari, Fabio
    Luca, Fabiana
    Caldarola, Pasquale
    Lucci, Donata
    Gabrielli, Domenico
    Di Lenarda, Andrea
    Gulizia, Michele Massimo
    BMJ OPEN, 2020, 10 (12):
  • [34] Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome
    Olivier, Christoph B.
    Turakhia, Mintu P.
    Mahaffey, Kenneth W.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (03) : 251 - 258
  • [35] Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysis
    Dawwas, Ghadeer K.
    Barnes, Geoffrey D.
    Dietrich, Eric
    Cuker, Adam
    Leonard, Charles E.
    Genuardi, Michael, V
    Lewis, James D.
    AMERICAN HEART JOURNAL, 2021, 242 : 71 - 81
  • [36] Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians
    Santoso, Anwar
    Raharjo, Sunu B.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2020, 29 (02) : 88 - 97
  • [37] Anticoagulation for Atrial Fibrillation: New Oral Anticoagulants?
    Omran, H.
    von der Recke, G.
    AKTUELLE KARDIOLOGIE, 2012, 1 (03) : 192 - 198
  • [38] The new oral anticoagulants in atrial fibrillation: an update
    Verheugt, F. W. A.
    NETHERLANDS HEART JOURNAL, 2013, 21 (11) : 480 - 484
  • [39] Warfarin or novel oral anticoagulants for atrial fibrillation?
    Larsen, Torben Bjerregaard
    Lip, Gregory Y. H.
    LANCET, 2014, 383 (9921): : 931 - 933
  • [40] Direct Oral Anticoagulants and Mortality in Atrial Fibrillation
    Ellis, Martin
    Ruslan, Sergienko
    Ariel, Hammerman
    Greenberg-Dotan, Sari
    Battat, Erez
    Hamburger-Avnery, Orly
    Greenberg, Dan
    Ronen, Arbel
    BLOOD, 2018, 132
12345